HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies

Transfusion

Volumn 54, Issue 8, 2014, Pages 1971-1980

  Schonewille, Henk ^a,b   Doxiadis, Ilias I N ^b   Levering, Wilfried H B M ^c   Roelen, Dave L ^b   Claas, Frans H J ^b   Brand, Anneke ^b  

^a SANQUIN RESEARCH   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIBODY; ERYTHROCYTE ANTIGEN; HLA DRB1 ANTIGEN; RHESUS C ANTIBODY; RHESUS D ANTIBODY; RHESUS E ANTIBODY; RHESUS FY ANTIBODY; RHESUS K ANTIBODY; RHESUS S ANTIBODY; UNCLASSIFIED DRUG;

ALLELE; ALLOIMMUNIZATION; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; COHORT ANALYSIS; DOSE RESPONSE; ERYTHROCYTE TRANSFUSION; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREGNANCY;

BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; DISEASE SUSCEPTIBILITY; ERYTHROCYTES; FEMALE; GENE FREQUENCY; GENES, MHC CLASS II; HISTOCOMPATIBILITY TESTING; HLA-DRB1 CHAINS; HUMANS; IMMUNIZATION; ISOANTIBODIES; ISOANTIGENS; MALE; ODDS RATIO; PREGNANCY; TRANSPLANTATION IMMUNOLOGY;

EID: 84906267912     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12624     Document Type: Article

References (42)

1. Stott LM, Barker RN, Urbaniak J,. Identification of alloreactive T-cell epitopes on the Rhesus D protein. Blood 2000; 96: 4011-4019.
2. Sukati H, Watson HG, Urbaniak SJ, et al. Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura. Blood 2007; 109: 4528-4538.
3. Stephen J, Cairns LS, Pickford WJ, et al. Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K blood group antigen. Blood 2012; 119: 5563-5574.
4. a immunization. Transfusion 2005; 45: 956-959.
5. a and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion 2006; 46: 1328-1333.
6. a immunization in a Southern European population. Transfusion 2009; 49: 2412-2417.
7. Chiaroni J, Dettori I, Ferrera V, et al. HLA-DRB1 polymorphism is associated with Kell immunisation. Br J Haematol 2006; 132: 374-378.
8. Chu CC, Ho HT, Lee HL, et al. Anti-"Mi(a)" immunization is associated with HLA-DRB10901. Transfusion 2009; 49: 472-478.
9. Hall AM, Cairns LS, Altmann DM, et al. Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood 2005; 105: 2175-2179.
10. Zalpuri S, Zwaginga JJ, le Cessie S, et al. Red-blood-cell alloimmunization and number of red-blood-cell transfusions. Vox Sang 2012; 102: 144-149.
11. Schonewille H, van de Watering LM, Brand A,. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 2006; 46: 630-635.
12. Schonewille H, Klumper FJ, van de Watering LM, et al. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus. Am J Obstet Gynecol 2007; 196: 143.e1-1436.
13. Schonewille H, de Vries RR, Brand A,. Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients. Transfusion 2009; 49: 453-457.
14. Pomper GJ, Simpson MB,. The prevention of alloimmunization: a balance of precaution, expectation, and outcome [editorial]. Transfusion 2009; 49: 406-408.
15. Schreuder GM, Hendriks GF, D'Amaro J, et al. An eight-year study of HLA typing proficiency in Eurotransplant. Tissue Antigens 1986; 27: 131-141.
16. Verduyn W, Doxiadis II, Anholts J, et al. Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant. Hum Immunol 1993; 37: 59-67.
17. Winters JL, Richa EM, Bryant SC, et al. Polyethylene glycol antiglobulin tube versus gel microcolumn: influence on the incidence of delayed hemolytic transfusion reactions and delayed serologic transfusion reactions. Transfusion 2010; 50: 1444-1452.
18. Svejgaard A, Ryder LP,. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994; 43: 18-27.
19. a red blood cell protein inducing either Th1 or Th2 cytokine expression. Blood 2004; 104: 3409-3410.
20. Hildén JO, Gottvall T, Lindblom B,. HLA phenotypes and severe Rh(D) immunization. Tissue Antigens 1995; 46: 313-315.
21. Darke C, Street J, Sargeant C, et al. HLA-DR antigens and properdine factor B allotypes in responders and non-responders to the Rhesus-D antigen. Tissue Antigens 1983; 21: 333-335.
22. Shankar Kumar U, Ghosh K, Gupte SS, et al. Role of HLA antigens in Rh (D) alloimmunized pregnant women from Mumbai, Maharashtra, India. J. BioSci. 2002; 27: 135-141.
23. Pan Q, Fan S, Wang X, et al. The distribution of HLA-A, -B, and -DRB1 alleles and haplotypes in inhabitants of Guizhou Province of China. J. Biomed. Res. 2011; 25: 328-334.
24. Qin Qin P, Su F, Xiao Yan W, et al. Distribution of human leucocyte antigen-A, -B and -DR alleles and haplotypes at high resolution in the population from Jiangsu province of China. Int J Immunogenet 2011; 38: 475-481.
25. Reed M, Lomas-Francis C,. The blood group antigen facts book. 2nd ed. London, UK: Academic Press; 2007.
26. Hoeltge GA, Domen RE, Rybicki LA, et al. Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995; 119: 42-45.
27. Schonewille H, Brand A,. Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study. Br J Haematol 2005; 129: 151-156.
28. Koelewijn JM, Vrijkotte TG, van der Schoot CE, et al. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion 2008; 48: 941-952.
29. Natukunda B, Schonewille H, van de Watering L, et al. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Vox Sang 2010; 98: 167-171.et al.
30. M'baya B, Mfune T, Mogombo E, et al. The prevalence of red-cell antigens and antibodies in Malawi. Transfus Med. 2010; 20: 196-199.
31. Natukunda B, Mugyenyi G, Brand A, et al. Maternal red blood cell alloimmunisation in south western Uganda. Transfus Med. 2011; 21: 262-266.
32. Noble JA, Johnson J, Lane JA, et al. Race-specific type 1 diabetes risk of HLA-DR7 haplotypes. Tissue Antigens 2011; 78: 348-351.
33. Jacobson RM, Ovsyannikova IG, Vierkant RA, et al. Human leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: persistence, dampening, and extinction of associations found after a first dose. Vaccine 2011; 29: 7982-7991.
34. Su LF, Kidd BA, Han A, et al. Virus-specific CD4+ memory-phenotype T cells are abundant in unexposed adults. Immunology 2013; 38: 373-383.
35. Amir AL, D'Orsogna LJ, Roelen DL, et al. Allo-HLA reactivity of virus-specific memory T-cells is common. Blood 2010; 115: 3146-3157.
36. Saunthararajah Y, Nakamura R, Nam JM, et al. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood 2002; 100: 1570-1574.
37. Song EY, Kang HJ, Shin HY, et al. Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients. Hum Immunol 2010; 71: 88-92.
38. Kritikou-Griva E, Spyropoulou-Vlachou M, Tsagarakis NJ, et al. High frequency of human leukocyte antigen class II DRB11602 haplotype in Greek patients with myelodysplastic syndrome and of DRB11501 in the low-risk subgroup. Human Immunol 2012; 73: 278-281.
39. Sutedja NA, Otten HG, Cats EA, et al. Increased frequency of HLA-DRB115 in patients with multifocal motor neuropathy. Neurology 2010; 74: 828-832.
40. Chao MJ, Barnardo MC, Lincoln MR, et al. HLA class I alleles tag HLA-DRB11501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc Natl Acad Sci U S A 2008; 105: 13069-13074.
41. Bendtzen K, Morling N, Fomsgaard A, et al. Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol 1988; 28: 599-606.
42. L'Abbé D, Tremblay L, Filion M, et al. Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB30101 and HLA-DQB10201. Hum Immunol 1992; 34: 107-114.